Bibliographical noteFunding Information:
after irradiation may not be active in vivo, but at present it seems prudent to consider that the trans- fusion of whole blood of any age or following irradiation may be a potential hazard for patients with impaired immune responses. This study was supported in part by U.S.P.H.S. 10695-02 and AI 06931. Requests for reprints should be addressed to J. McC., Depart-ment of Medicine, Vanderbilt University, Nashville, Tennessee, 37203.
This record is sourced from MEDLINE/PubMed, a database of the U.S. National Library of Medicine